Apixaban Market Size, Share Report, Analysis, Trends, Growth, 2030
Apixaban Market By Dosage Form (Capsule and Tablet), By End-User (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 - 2030
Category: Pharmaceutical Report Format : PDF
Pages: 204 Report Code: ZMR-4983
Published Date: Oct-2023 Status : Published
| Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 11 Billion | USD 17 Billion | 7% | 2022 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Apixaban Market, (2023 - 2030) (USD Billion)
- 2.2 Global Apixaban Market : snapshot
- Chapter 3. Global Apixaban Market - Industry Analysis
- 3.1 Apixaban Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Growing incidences of venous thromboembolism-related ailments will steer the global market trends
- 3.3 Market Restraints
- 3.3.1. Adverse drug effects on patients can put brakes on the global industry surge by 2030
- 3.4 Market Opportunities
- 3.4.1. Huge government investments in healthcare industry will open new growth avenues for the global market over 2023-2030
- 3.5 Market Challenges
- 3.5.1. Low access to proper drug treatment in emerging economies can be a key challenge for the industry across the globe
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Dosage Form
- 3.7.2 Market attractiveness analysis By End-User
- Chapter 4. Global Apixaban Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Apixaban Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Apixaban Market - Dosage Form Analysis
- 5.1 Global Apixaban Market overview: By Dosage Form
- 5.1.1 Global Apixaban Market share, By Dosage Form, 2022 and 2030
- 5.2 Capsule
- 5.2.1 Global Apixaban Market by Capsule, 2023 - 2030 (USD Billion)
- 5.3 Tablet
- 5.3.1 Global Apixaban Market by Tablet, 2023 - 2030 (USD Billion)
- 5.1 Global Apixaban Market overview: By Dosage Form
- Chapter 6. Global Apixaban Market - End-User Analysis
- 6.1 Global Apixaban Market overview: By End-User
- 6.1.1 Global Apixaban Market share, By End-User, 2022 and 2030
- 6.2 Hospitals
- 6.2.1 Global Apixaban Market by Hospitals, 2023 - 2030 (USD Billion)
- 6.3 Clinics
- 6.3.1 Global Apixaban Market by Clinics, 2023 - 2030 (USD Billion)
- 6.4 Retail Pharmacies
- 6.4.1 Global Apixaban Market by Retail Pharmacies, 2023 - 2030 (USD Billion)
- 6.5 Online Pharmacies
- 6.5.1 Global Apixaban Market by Online Pharmacies, 2023 - 2030 (USD Billion)
- 6.6 Others
- 6.6.1 Global Apixaban Market by Others, 2023 - 2030 (USD Billion)
- 6.1 Global Apixaban Market overview: By End-User
- Chapter 7. Apixaban Market - Regional Analysis
- 7.1 Global Apixaban Market Regional Overview
- 7.2 Global Apixaban Market Share, by Region, 2022 & 2030 (USD Billion)
- 7.3. North America
- 7.3.1 North America Apixaban Market, 2023 - 2030 (USD Billion)
- 7.3.1.1 North America Apixaban Market, by Country, 2023 - 2030 (USD Billion)
- 7.3.1 North America Apixaban Market, 2023 - 2030 (USD Billion)
- 7.4 North America Apixaban Market, by Dosage Form, 2023 - 2030
- 7.4.1 North America Apixaban Market, by Dosage Form, 2023 - 2030 (USD Billion)
- 7.5 North America Apixaban Market, by End-User, 2023 - 2030
- 7.5.1 North America Apixaban Market, by End-User, 2023 - 2030 (USD Billion)
- 7.4. Europe
- 7.4.2 Europe Apixaban Market, 2023 - 2030 (USD Billion)
- 7.4.2.1 Europe Apixaban Market, by Country, 2023 - 2030 (USD Billion)
- 7.4.2 Europe Apixaban Market, 2023 - 2030 (USD Billion)
- 7.4 Europe Apixaban Market, by Dosage Form, 2023 - 2030
- 7.4.1 Europe Apixaban Market, by Dosage Form, 2023 - 2030 (USD Billion)
- 7.5 Europe Apixaban Market, by End-User, 2023 - 2030
- 7.5.1 Europe Apixaban Market, by End-User, 2023 - 2030 (USD Billion)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Apixaban Market, 2023 - 2030 (USD Billion)
- 7.5.3.1 Asia Pacific Apixaban Market, by Country, 2023 - 2030 (USD Billion)
- 7.5.3 Asia Pacific Apixaban Market, 2023 - 2030 (USD Billion)
- 7.4 Asia Pacific Apixaban Market, by Dosage Form, 2023 - 2030
- 7.4.1 Asia Pacific Apixaban Market, by Dosage Form, 2023 - 2030 (USD Billion)
- 7.5 Asia Pacific Apixaban Market, by End-User, 2023 - 2030
- 7.5.1 Asia Pacific Apixaban Market, by End-User, 2023 - 2030 (USD Billion)
- 7.6. Latin America
- 7.6.4 Latin America Apixaban Market, 2023 - 2030 (USD Billion)
- 7.6.4.1 Latin America Apixaban Market, by Country, 2023 - 2030 (USD Billion)
- 7.6.4 Latin America Apixaban Market, 2023 - 2030 (USD Billion)
- 7.4 Latin America Apixaban Market, by Dosage Form, 2023 - 2030
- 7.4.1 Latin America Apixaban Market, by Dosage Form, 2023 - 2030 (USD Billion)
- 7.5 Latin America Apixaban Market, by End-User, 2023 - 2030
- 7.5.1 Latin America Apixaban Market, by End-User, 2023 - 2030 (USD Billion)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Apixaban Market, 2023 - 2030 (USD Billion)
- 7.7.5.1 The Middle-East and Africa Apixaban Market, by Country, 2023 - 2030 (USD Billion)
- 7.7.5 The Middle-East and Africa Apixaban Market, 2023 - 2030 (USD Billion)
- 7.4 The Middle-East and Africa Apixaban Market, by Dosage Form, 2023 - 2030
- 7.4.1 The Middle-East and Africa Apixaban Market, by Dosage Form, 2023 - 2030 (USD Billion)
- 7.5 The Middle-East and Africa Apixaban Market, by End-User, 2023 - 2030
- 7.5.1 The Middle-East and Africa Apixaban Market, by End-User, 2023 - 2030 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 F. Hoffmann-La Roche Ltd
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Hikma Pharmaceuticals PLC
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Eisai Co. Ltd
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Sanofi S.A.
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Yino Pharma Limited
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Mylan N.V.
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Bristol Myers Squibb Company
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Abbott Laboratories
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Hebei Changshan Biochemical Pharmaceutical Co. Ltd
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Nanjing Jianyou Biochemical Pharmaceutical Co. Ltd.
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 Aspen Holdings
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 Fresenius Kabi AG
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 Pfizer Inc.
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.14 and others.
- 8.14.1 Overview
- 8.14.2 Financials
- 8.14.3 Product Portfolio
- 8.14.4 Business Strategy
- 8.14.5 Recent Developments
- 8.1 F. Hoffmann-La Roche Ltd
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Apixaban Market, 2023 - 2030 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Apixaban Market attractiveness, By Dosage Form
- 6. Global Apixaban Market attractiveness, By End-User
- 7. Global Apixaban Market share by Dosage Form, 2023 and 2030 (USD Billion)
- 8. Global Apixaban Market by Capsule, 2023 - 2030 (USD Billion)
- 9. Global Apixaban Market by Tablet, 2023 - 2030 (USD Billion)
- 10. Global Apixaban Market share by End-User, 2023 and 2030 (USD Billion)
- 11. Global Apixaban Market by Hospitals, 2023 - 2030 (USD Billion)
- 12. Global Apixaban Market by Clinics, 2023 - 2030 (USD Billion)
- 13. Global Apixaban Market by Retail Pharmacies, 2023 - 2030 (USD Billion)
- 14. Global Apixaban Market by Online Pharmacies, 2023 - 2030 (USD Billion)
- 15. Global Apixaban Market by Others, 2023 - 2030 (USD Billion)
- 16. Global Apixaban Market share, by Region, 2023 and 2030
- 17. North America Apixaban Market, 2023 - 2030 (USD Billion)
- 18. Europe Apixaban Market, 2023 - 2030 (USD Billion)
- 19. Asia Pacific Apixaban Market, 2023 - 2030 (USD Billion)
- 20. Latin America Apixaban Market, 2023 - 2030 (USD Billion)
- 21. The Middle-East and Africa Apixaban Market, 2023 - 2030 (USD Billion)
Table Of Tables
- 1. Global Apixaban Market: Snapshot
- 2. Drivers of the Apixaban Market: impact analysis
- 3. North America Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 4. North America Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 5. U.S. Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 6. U.S. Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 7. Canada Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 8. Canada Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 9. Europe Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 10. Europe Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 11. Germany Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 12. Germany Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 13. France Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 14. France Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 15. U.K. Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 16. U.K. Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 17. Italy Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 18. Italy Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 19. Spain Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 20. Spain Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 21. Rest of Europe Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 22. Rest of Europe Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 23. Asia Pacific Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 24. Asia Pacific Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 25. China Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 26. China Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 27. Japan Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 28. Japan Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 29. India Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 30. India Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 31. South Korea Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 32. South Korea Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 33. South-East Asia Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 34. South-East Asia Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 35. Rest of Asia Pacific Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 36. Rest of Asia Pacific Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 37. Latin America Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 38. Latin America Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 39. Brazil Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 40. Brazil Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 41. Mexico Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 42. Mexico Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 43. Rest of Latin America Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 44. Rest of Latin America Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 45. The Middle-East and Africa Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 46. The Middle-East and Africa Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 47. GCC Countries Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 48. GCC Countries Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 49. South Africa Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 50. South Africa Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 51. Rest of Middle-East Africa Apixaban Market revenue, By Dosage Form, 2023 - 2030 (USD Billion)
- 52. Rest of Middle-East Africa Apixaban Market revenue, By End-User, 2023 - 2030 (USD Billion)
Methodology
FrequentlyAsked Questions
Apixaban mechanism works on Xa factor inhibiting which indirectly decreases thrombin-stimulated clot formation.
The global apixaban market growth can be owing to a rise in the occurrence of venous thromboembolism-related ailments.
According to a study, the global apixaban industry size was $11 billion in 2022 and is projected to reach $17 billion by the end of 2030.
The global apixaban market is anticipated to record a CAGR of nearly 7% from 2023 to 2030.
The Asia-Pacific apixaban industry is set to register the highest CAGR over the forecasting timeline owing to the presence of strong healthcare infrastructure in countries such as India and China. In addition to this, supportive healthcare initiatives by governments in these countries will further prompt regional industry growth.
The global apixaban market is led by players such as F. Hoffmann-La Roche Ltd, Hikma Pharmaceuticals PLC, Eisai Co., Ltd, Sanofi S.A., Yino Pharma Limited, Mylan N.V., Bristol Myers Squibb Company, Abbott Laboratories, Hebei Changshan Biochemical Pharmaceutical Co. Ltd, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., Aspen Holdings, Fresenius Kabi AG, and Pfizer Inc.
The apixaban market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed